Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination

Vaccine

Volumn 31, Issue 19, 2013, Pages 2333-2342

  Dunne, Eileen M ^a   Smith Vaughan, Heidi C ^b   Robins Browne, Roy M ^a,c   Mulholland, E Kim ^a,b,d   Satzke, Catherine ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Colonisation; Microbial interactions; Nasopharynx; Pneumococcal vaccines; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOSIS; BACTERIUM ADHERENCE; CHILDHOOD DISEASE; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; HUMAN; INNATE IMMUNITY; LOWEST INCOME GROUP; MICROBIAL COLONIZATION; MORAXELLA CATARRHALIS; NONHUMAN; ORGANISMAL INTERACTION; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOPHARYNGITIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS DETECTION; VIRUS INFECTION;

CARRIER STATE; CHILD; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL INTERACTIONS; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84876081088     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.024     Document Type: Review

References (113)

1. Wardlaw T., Salama P., Johansson E.W., Mason E. Pneumonia: the leading killer of children. Lancet 2006, 368(9541):1048-1050.
2. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902.
3. Murphy T., Parameswaran G. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 2009, 49:124-131.
4. Vergison A. Microbiology of otitis media: a moving target. Vaccine 2008, 26(Suppl. 7):G5-G10.
5. Murphy T.F., Bakaletz L.O., Smeesters P.R. Microbial interactions in the respiratory tract. Pediatr Infect Dis J 2009, 28(10):S121-S126.
6. Leach A.J., Morris P.S. The burden and outcome of respiratory tract infection in Australian and Aboriginal children. Pediatr Infect Dis J 2007, 26(10):S4-S7.
7. García-Rodríguez J.Á., Fresnadillo Martínez M.J. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother 2002, 50(Suppl. 3):59-74.
8. Russell F.M., Carapetis J.R., Ketaiwai S., Kunabuli V., Taoi M., Biribo S., et al. Pneumococcal nasopharyngeal carriage and patterns of penicillin resistance in young children in Fiji. Ann Trop Paediatr 2006, 26(3):187-197.
9. Jourdain S., Smeesters P.R., Denis O., Dramaix M., Sputael V., Malaviolle X., et al. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins. Clin Microbiol Infect 2011, 17(6):907-914.
10. Principi N., Marchisio P., Schito G.C., Mannelli S., Group T.A.P.C. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediatr Infect Dis J 1999, 18(6):517-523.
11. Brugger S.D., Frey P., Aebi S., Hinds J., Mühlemann K. Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine. PLoS ONE 2010, 5(7):e11638.
12. Weinberger D.M., Malley R., Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378(9807):1962-1973.
13. Hsieh Y-C., Lin P-Y., Chiu C-H., Huang Y-C., Chang K-Y., Liao C-H., et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009, 27(40):5513-5518.
14. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297(16):1784-1792.
15. Regev-Yochay G., Dagan R., Raz M., Carmeli Y., Shainberg B., Derazne E., et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 2004, 292(6):716-720.
16. Bogaert D., van Belkum A., Sluijter M., Luijendijk A., de Groot R., Rümke H.C., et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004, 363(9424):1871-1872.
17. Russell C.D. Streptococcus vaccination and MRSA. Lancet Infect Dis 2012, 12(8):586.
18. Casey J.R., Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004, 23(9):824-828.
19. Wiertsema S.P., Kirkham L-A.S., Corscadden K.J., Mowe E.N., Bowman J.M., Jacoby P., et al. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 2011, 29(32):5163-5170.
20. Stamboulidis K., Chatzaki D., Poulakou G., Ioannidou S., Lebessi E., Katsarolis I., et al. The Impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011, 30(7):551-555.
21. Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5(12):751-762.
22. Rudan I., Boschi-Pinto C., Biloglav Z., Mulholland K., Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008, 86(May (5)):408-416.
23. Frei C.R., Makos B.R., Daniels K.R., Oramasionwu C.U. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg 2010, 45(10):1967-1974.
24. Xu Q., Almudervar A., Casey J.R., Pichichero M.E. Nasopharyngeal bacterial interactions in children. Emerg Infect Dis 2012, 18(11):1738-1745.
25. Smith-Vaughan H., Byun R., Nadkarni M., Jacques N., Hunter N., Halpin S., et al. Measuring nasal bacterial load and its association with otitis media. BMC Ear NoseThroat Disord 2006, 6(1):10.
26. Tosi M.F. Innate immune responses to infection. J Allergy Clin Immunol 2005, 116(2):241-249.
27. Brook I., Gober A.E. The effects of treatment of acute otitis media with a low dose vs a high dose of amoxicillin on the nasopharyngeal flora. Arch Otolaryngol Head Neck Surg 2009, 135(5):458-461.
28. Quintero B., Araque M., van der Gaast-de Jongh C., Escalona F., Correa M., Morillo-Puente S., et al. Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. Eur J Clin Microbiol Infect Dis 2011, 30(1):7-19.
29. Kwambana B., Barer M., Bottomley C., Adegbola R., Antonio M. Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants. BMC Infect Dis 2011, 11(1):175.
30. Bae S., Yu J-Y., Lee K., Lee S., Park B., Kang Y. Nasal colonization by four potential respiratory bacteria in healthy children attending kindergarten or elementary school in Seoul, Korea. J Med Microbiol 2012, 61(Pt 5):678-685.
31. Kuo C-Y., Hwang K-P., Hsieh Y-C., Cheng C-H., Huang F-L., Shen Y-H., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 2011, 29(32):5171-5177.
32. Dukers-Muijrers NH, Stobberingh E, Beisser P, Boesten RC, Jacobs P, Hoebe CJ. Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children. Epidemiol Infect 2012:1-8.
33. Lee G., Huang S., Rifas-Shiman S., Hinrichsen V., Pelton S., Kleinman K., et al. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis 2009, 9(1):110.
34. Jacoby P., Watson K., Bowman J., Taylor A., Riley T.V., Smith D.W., et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine 2007, 25(13):2458-2464.
35. Regev-Yochay G., Trzcinski K., Thompson C.M., Malley R., Lipsitch M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol 2006, 188(13):4996-5001.
36. Selva L., Viana D., Regev-Yochay G., Trzcinski K., Corpa J.M., Lasa I., et al. Killing niche competitors by remote-control bacteriophage induction. Proc Natl Acad Sci USA 2009, 106(4):1234-1238.
37. Margolis E. Hydrogen peroxide-mediated interference competition by Streptococcus pneumoniae has no significant effect on Staphylococcus aureus nasal colonization of neonatal rats. J Bacteriol 2009, 191(2):571-575.
38. Regev-Yochay G., Malley R., Rubinstein E., Raz M., Dagan R., Lipsitch M. In vitro bactericidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized children. J Clin Microbiol 2008, 46(2):747-749.
39. Melles D.C., Bogaert D., Gorkink R.F.J., Peeters J.K., Moorhouse M.J., Ott A., et al. Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 2007, 153(3):686-692.
40. Barocchi M.A., Ries J., Zogaj X., Hemsley C., Albiger B., Kanth A., et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci USA 2006, 103(8):2857-2862.
41. Nelson A.L., Ries J., Bagnoli F., Dahlberg S., Fälker S., Rounioja S., et al. RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol 2007, 66(2):329-340.
42. Regev-Yochay G., Lipsitch M., Basset A., Rubinstein E., Dagan R., Raz M., et al. The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers. Clin Infect Dis 2009, 48(March (6)):760-763.
43. Basset A., Trzcinski K., Hermos C., O'Brien K.L., Reid R., Santosham M., et al. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol 2007, 45(June (6)):1684-1689.
44. Bhattacharya S.D., Niyogi S.K., Bhattacharyya S., Arya B.K., Chauhan N., Mandal S. Associations between potential bacterial pathogens in the nasopharynx of HIV infected children. Indian J Pediatr 2012, 79(11):1447-1453.
45. Madhi S.A., Adrian P., Kuwanda L., Cutland C., Albrich W.C., Klugman K.P. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae-and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization-in HIV-infected and HIV-uninfected children. J Infect Dis 2007, 196(11):1662-1666.
46. Lebon A., Verkaik N.J., de Vogel C.P., Hooijkaas H., Verbrugh H.A., van Wamel W.J.B., et al. The inverse correlation between Staphylococcus aureus and Streptococcus pneumoniae colonization in infants is not explained by differences in serum antibody levels in the Generation R Study. Clin Vaccine Immunol 2011, 18(1):180-183.
47. Vuononvirta J., Toivonen L., Gröndahl-Yli-Hannuksela K., Barkoff A-M., Lindholm L., Mertsola J., et al. Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants. PLoS ONE 2011, 6(10):e26198.
48. Verhaegh S.J.C., Snippe M.L., Levy F., Verbrugh H.A., Jaddoe V.W.V., Hofman A., et al. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. Microbiology 2011, 157(1):169-178.
49. Shak J.R., Vidal J.E., Klugman K.P. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol 2013, 21(3):129-135.
50. Weimer K.E.D., Juneau R.A., Murrah K.A., Pang B., Armbruster C.E., Richardson S.H., et al. Divergent mechanisms for passive pneumococcal resistance to β-Lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis 2011, 203(4):549-555.
51. Armbruster CE, Hong W, Pang B, Weimer KED, Juneau RA, Turner J, et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio 2010;1(3):e00102-10-e-19.
52. Cope E.K., Goldstein-Daruech N., Kofonow J.M., Christensen L., McDermott B., Monroy F., et al. Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease. PLoS ONE 2011, 6(12):e28523.
53. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296(2):202-211.
54. Thornton R., Rigby P., Wiertsema S., Filion P., Langlands J., Coates H., et al. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatrics 2011, 11(1):94.
55. Margolis E., Yates A., Levin B. The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response. BMC Microbiol 2010, 10(1):59.
56. Hovig B., Aandahl E.H. A selective method for the isolation of Haemophilus in material from the respiratory tract. Acta Pathol Microbiol Scand 1969, 77(4):676-684.
57. Lysenko E.S., Ratner A.J., Nelson A.L., Weiser J.N. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog 2005, 1(1):e1.
58. Cobey S., Lipsitch M. Pathogen diversity and hidden regimes of apparent competition. Am Nat 2013, 181(January (1)):12-24.
59. Dunne E.M., Manning J., Russell F.M., Robins-Browne R.M., Mulholland E.K., Satzke C. Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol 2012, 50(3):1034-1038.
60. Montgomery J.M., Lehmann D., Smith T., Michael A., Joseph B., Lupiwa T., et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in highland children of Papua New Guinea. Rev Infect Dis 1990, 12:S1006-S1016.
61. Watson K., Carville K., Bowman J., Jacoby P., Riley T.V., Leach A.J., et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 2006, 25(9):782-790.
62. Pettigrew M.M., Gent J.F., Revai K., Patel J.A., Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis 2008, 14(10):1584-1591.
63. Spijkerman J., Prevaes S.M.P.J., van Gils E.J.M., Veenhoven R.H., Bruin J.P., Bogaert D., et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS ONE 2012, 7(6):e39730.
64. Ho P-L., Chiu S.S., Chan M.Y., Gan Y., Chow K-H., Lai E.L., et al. Molecular epidemiology and nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus among young children attending day care centers and kindergartens in Hong Kong. J Infect 2012, 64(5):500-506.
65. van Gils E.J.M., Hak E., Veenhoven R.H., Rodenburg G.D., Bogaert D., Bruin J.P., et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS ONE 2011, 6(6):e20229.
66. van Gils E.J.M., Veenhoven R.H., Rodenburg G.D., Hak E., Sanders E.A.M. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 2011, 29(44):7595-7598.
67. Dagan R., Klugman K.P. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008, 8(12):785-795.
68. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006, 367(9512):740-748.
69. Prymula R., Kriz P., Kaliskova E., Pascal T., Poolman J., Schuerman L. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 2009, 28(1):71-78.
70. Prymula R., Hanovcova I., Splino M., Kriz P., Motlova J., Lebedova V., et al. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine 2011, 29(10):1959-1967.
71. Kim C.-H., Kim J.S., Cha S-H., Kim K.-N., Kim J.-D., Lee K.Y., et al. Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae Protein D conjugate vaccine in Korean infants. Pediatr Infect Dis J 2011, 30(12):e235-e243.
72. Rodgers GL, Klugman KP. The future of pneumococcal disease prevention. Vaccine 2011;29(Suppl. 3(0)):C43-8.
73. Moffitt K.L., Malley R. Next generation pneumococcal vaccines. Curr Opin Immunol 2011, 23(3):407-413.
74. Murdoch D.R., O'Brien K.L., Driscoll A.J., Karron R.A., Bhat N., et al. Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis 2012, 54(Suppl. 2):S146-S152.
75. Veenhoven R., Bogaert D., Uiterwaal C., Brouwer C., Kiezebrink H., Bruin J., et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003, 361(June (9376)):2189-2195.
76. Cohen R., Levy C., Thollot F., de La Rocque F., Koskas M., Bonnet E., et al. Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media. Clin Infect Dis 2007, 45(12):1583-1587.
77. Casey J.R., Adlowitz D.G., Pichichero M.E. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate accine. Pediatr Infect Dis J 2010, 29(4):304-309.
78. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004, 23(9):829-833.
79. Coker T.R., Chan L.S., Newberry S.J., Limbos M.A., Suttorp M.J., Shekelle P.G., et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 2010, 304(19):2161-2169.
80. Revai K., McCormick D.P., Patel J., Grady J.J., Saeed K., Chonmaitree T. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics 2006, 117(5):1823-1829.
81. Pettigrew M.M., Gent J.F., Pyles R.B., Miller A.L., Nokso-Koivisto J., Chonmaitree T. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol 2011, 49(11):3750-3755.
82. Binks M., Cheng A., Smith-Vaughan H., Sloots T., Nissen M., Whiley D., et al. Viral-bacterial co-infection in Australian Indigenous children with acute otitis media. BMC Infect Dis 2011, 11(1):161.
83. Kwambana B., Mohammed N., Jeffries D., Barer M., Adegbola R., Antonio M. Differential effects of frozen storage on the molecular detection of bacterial taxa that inhabit the nasopharynx. BMC Clin Pathol 2011, 11(1):2.
84. Biesbroek G., Sanders E.A.M., Roeselers G., Wang X., Caspers M.P.M., Trzciński K., et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS ONE 2012, 7(3):e32942.
85. Bogaert D., Keijser B., Huse S., Rossen J., Veenhoven R., van Gils E., et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS ONE 2011, 6(2):e17035.
86. Pettigrew M.M., Laufer A.S., Gent J.F., Kong Y., Fennie K.P., Metlay J.P. Upper respiratory tract microbial communities, acute otitis media pathogens and antibiotic use in healthy and sick children. Appl Environ Microbiol 2012, 78(17):6262-6270.
87. Hilty M., Qi W., Brugger S.D., Frei L., Agyeman P., Frey P.M., et al. Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis 2012, 205(7):1048-1055.
88. Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, Pettigrew MM. Microbial communities of the upper respiratory tract and otitis media in children. mBio 2011;2(1).
89. Hill D.J., Griffiths N.J., Borodina E., Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci 2010, 118(9):547-564.
90. Graham S.M., Molyneux E.M., Walsh A.L., Cheesbrough J.S., Molyneux M.E., Hart C.A. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 2000, 19(December (12)):1189-1196.
91. Bosch A.A., Biesbroek G., Trzcinski K., Sanders E.A., Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog 2013, 9(1):e1003057.
92. Hament J-M., Kimpen J.L.L., Fleer A., Wolfs T.F.W. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999, 26(3-4):189-195.
93. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006, 19(3):571-582.
94. Koon K., Sanders C.M., Green J., Malone L., White H., Zayas D., et al. Co-detection of pandemic (H1N1) 2009 virus and other respiratory pathogens. Emerg Infect Dis 2010, 16(12):1976-1978.
95. Palacios G., Hornig M., Cisterna D., Savji N., Bussetti A.V., Kapoor V., et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE 2009, 4(12):e8540.
96. Masia M., Padilla S., Antequera P., Ramos J.M., Ruiz M., Gutierrez F. Predictors of pneumococcal co-infection for patients with pandemic (H1N1) 2009. Emerg Infect Dis 2011, 17(8):1475-1478.
97. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009;58(October (38)):1071-4.
98. Short K.R., Habets M.N., Hermans P.W., Diavatopoulos D.A. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship. Future Microbiol 2012, 7:609-624.
99. Diavatopoulos D.A., Short K.R., Price J.T., Wilksch J.J., Brown L.E., Briles D.E., et al. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J 2010, 24(6):1789-1798.
100. McCullers J.A., McAuley J.L., Browall S., Iverson A.R., Boyd K.L., Henriques Normark B. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010, 202(8):1287-1295.
101. Vu H.T.T., Yoshida L.M., Suzuki M., Nguyen H.A.T., Nguyen C.D.L., Nguyen A.T.T., et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011, 30(1):11-18.
102. Nakamura S., Davis K.M., Weiser J.N. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 2011, 121(9):3657-3665.
103. Mühlemann K., Uehlinger D.E., Büchi W., Gorgievski M., Aebi C. The prevalence of penicillin-non-susceptible Streptococcus pneumoniae among children aged <5 years correlates with the biannual epidemic activity of respiratory syncytial virus. Clin Microbiol Infect 2006, 12(9):873-879.
104. Verkaik N.J., Nguyen D.T., de Vogel C.P., Moll H.A., Verbrugh H.A., Jaddoe V.W.V., et al. Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection. Clin Microbiol Infect 2011, 17(12):1840-1844.
105. Moore H.C., Jacoby P., Taylor A., Harnett G., Bowman J., Riley T.V., et al. The interaction between respiratory viruses and pathogenic bacteria in the upper respiratory tract of asymptomatic Aboriginal and non-Aboriginal children. Pediatr Infect Dis J 2010, 29(6):540-545.
106. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10(August (8)):811-813.
107. Simonsen L., Taylor R.J., Young-Xu Y., Haber M., May L., Klugman K.P. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2011, 2(1):e00309-e310.
108. Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007, 369(9568):1179-1186.
109. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359(15):1555-1564.
110. Chidlow G., Harnett G., Shellam G., Smith D. An economical tandem multiplex real-time PCR technique for the detection of a comprehensive range of respiratory rathogens. Viruses 2009, 1(1):42-56.
111. Abdullahi O., Nyiro J., Lewa P., Slack M., Scott J.A. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi District, Kenya. Pediatr Infect Dis J 2008, 27:59-64.
112. Chien Y.W., Vidal J.E., Grijalva C.G., Bozio C., Edwards K.M., Williams J.V., et al. Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J 2013, 32(January (1)):72-77.
113. Lijek R.S., Luque S.L., Liu Q., Parker D., Bae T., Weiser J.N. Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase. Proc Natl Acad Sci USA 2012, 109(34):13823-13828.